Comparison

Auristatin E European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 250 mg
Item no. HY-15582-250mg
CASRN 160800-57-7
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAE analog and cytotoxin in antibody-drug conjugates. Auristatin E inhibits cell division by blocking the polymerisation of tubulin.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
732.01
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target
ADC Cytotoxin; Microtubule/Tubulin
Isoform
Auristatin
Pathway
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type
ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close